Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 1467 entries
View as:

Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases

Phase: N/A Priority: Normal
NCT ID: NCT02517385 Org: User:
Start: 08/31/15 End: 06/30/16 Due: 06/30/17

Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part I

Phase: N/A Priority: Normal
NCT ID: NCT01463488 Org: User:
Start: 11/30/11 End: 08/31/12 Due: 08/31/13

Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01193595 Org: User:
Start: 09/30/10 End: 10/31/14 Due: 10/31/15

Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00174746 Org: User:
Start: 03/31/05 End: 11/30/05 Due: 11/30/06

Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent Claudication

Phase: N/A Priority: Normal
NCT ID: NCT01157871 Org: User:
Start: 06/30/04 End: 08/31/05 Due: 08/31/06

PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)

Phase: N/A Priority: Normal
NCT ID: NCT00077805 Org: User:
Start: 08/31/03 End: - Due: -

CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision

Phase: N/A Priority: Normal
NCT ID: NCT00174616 Org: User:
Start: 07/31/03 End: 11/30/07 Due: 11/30/08

Artesunate Plus Amodiaquine in Malaria in Cote d'Ivoire

Phase: N/A Priority: Normal
NCT ID: NCT01023399 Org: User:
Start: 11/30/09 End: 10/31/13 Due: 10/31/14

Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT05279833 Org: User:
Start: 09/24/21 End: 03/31/22 Due: 03/31/23

Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01798706 Org: User:
Start: 06/30/13 End: 02/28/15 Due: 02/28/16

A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)

Phase: N/A Priority: Normal
NCT ID: NCT06101095 Org: User:
Start: 11/29/23 End: 02/01/28 Due: 02/01/29

Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)

Phase: N/A Priority: Normal
NCT ID: NCT04411641 Org: User:
Start: 09/24/20 End: 08/29/24 Due: 08/29/25

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)

Phase: N/A Priority: Normal
NCT ID: NCT04410991 Org: User:
Start: 06/11/20 End: 07/16/24 Due: 07/16/25

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)

Phase: N/A Priority: Normal
NCT ID: NCT04410978 Org: User:
Start: 06/30/20 End: 07/15/24 Due: 07/15/25

Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)

Phase: N/A Priority: Normal
NCT ID: NCT00653302 Org: User:
Start: 04/30/03 End: 10/31/05 Due: 10/31/06

Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01392924 Org: User:
Start: 08/31/11 End: 11/30/14 Due: 11/30/15

Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

Phase: N/A Priority: Normal
NCT ID: NCT04643002 Org: User:
Start: 01/25/21 End: 04/20/28 Due: 04/20/29

A Safety and Efficacy Study of SAR405838 and Pimasertib in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01985191 Org: User:
Start: 11/30/13 End: 02/29/16 Due: 02/28/17

SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM

Phase: N/A Priority: Normal
NCT ID: NCT05405166 Org: User:
Start: 06/23/22 End: 03/23/27 Due: 03/23/28

EXIBIT: Oxaliplatin in Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00174564 Org: User:
Start: 04/30/03 End: 09/30/06 Due: 09/30/07

Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Renal Impairment Compared to Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT05282030 Org: User:
Start: 03/10/22 End: 08/02/22 Due: 08/02/23

Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study

Phase: N/A Priority: Normal
NCT ID: NCT00232258 Org: User:
Start: 04/30/05 End: 09/30/06 Due: 09/30/07

Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)

Phase: N/A Priority: Normal
NCT ID: NCT00077792 Org: User:
Start: 10/31/02 End: 12/31/06 Due: 12/31/07

Amisulpride in Schizophrenic Acute Phase Patients

Phase: N/A Priority: Normal
NCT ID: NCT00436371 Org: User:
Start: 05/31/05 End: - Due: -

Dermatological Evaluation of Topic Compatibility-Dermacyd Tina Gel Tangerina Mix

Phase: N/A Priority: Normal
NCT ID: NCT00669058 Org: User:
Start: 12/31/07 End: - Due: -